Phillip D. Markham

11.3k citations

64 papers · 8.5k indexed · 2 hit papers · h-index 38

Virology top 0.05%
Epidemiology top 0.5%
Immunology top 0.5%
Infectious Diseases top 0.5%
Oncology top 1%

Co-authors: Robert C. Gallo Mark H. Kaplan S. Zaki Salahuddin Mikuláš Popovič Robert R. Redfield Syed Zaki Salahuddin Gene M. Shearer Barton F. Haynes
Topics: HIV Research and Treatment (38 papers)T-cell and Retrovirus Studies (20 papers)Herpesvirus Infections and Treatments (20 papers)
Cited by: Virology Immunology Infectious Diseases
Journals: Nature Science New England Journal of Medicine
Partner nations: United States Italy Sweden

In The Last Decade

Phillip D. Markham

61 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1984 2.8k citations Robert C. Gallo, Gene M. Shearer et al. profile →
Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative Disorders

1986 1.1k citations S. Zaki Salahuddin, Dharam V. Ablashi et al. profile →

Peers

Countries citing papers authored by Phillip D. Markham

Since Specialization

Citations

This map shows the geographic impact of Phillip D. Markham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip D. Markham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip D. Markham more than expected).

Fields of papers citing papers by Phillip D. Markham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip D. Markham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip D. Markham. The network helps show where Phillip D. Markham may publish in the future.

Co-authorship network of co-authors of Phillip D. Markham

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip D. Markham. A scholar is included among the top collaborators of Phillip D. Markham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip D. Markham. Phillip D. Markham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cellular Gene Expression Profiles in Rhesus Macaques Challenged Mucosally with a Pathogenic R5 Tropic Simian Human Immunodeficiency Virus Isolate 2008 ·Viral Immunology ·(unknown),Cynthia A. Pise-Masison,Michael F. Radonovich,John Brady,Jae K. Lee,(unknown),Phillip D. Markham,Anthony D. Cristillo,Ranajit Pal	6
2	Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers 2008 ·Vaccine ·Shixia Wang,Jeffrey S. Kennedy,Kim West,David C. Montefiori,Scott Coley,John F. Lawrence,Siyuan Shen,Sharone Green,Alan L. Rothman,Francis A. Ennis,James Arthos,Ranajit Pal,Phillip D. Markham,Shan Lu	84
3	Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation 2008 ·Vaccine ·Margherita Rosati,Antonio Valentin,Rashmi Jalah,Vainav Patel,Agneta von Gegerfelt,Cristina Bergamaschi,Candido Alicea,Deborah Weiss,(unknown),Ranajit Pal,Phillip D. Markham,Ernesto T. A. Marques,J. Thomas August,Amir Sada Khan,Ruxandra Draghia‐Akli,Barbara K. Felber,George N. Pavlakis	73
4	Development of real-time PCR assays for quantitation of simian betaretrovirus serotype-1, -2, -3, and -5 viral DNA in Asian monkeys 2008 ·Journal of Virological Methods ·(unknown),(unknown),(unknown),Deborah Weiss,Phillip D. Markham	9
5	Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors 2007 ·Journal of Virology ·Sampa Santra,Yue Sun,Jenny G. Parvani,Valérie Philippon,Michael S. Wyand,Kelledy Manson,(unknown),Gail P. Mazzara,Dennis Panicali,Phillip D. Markham,David C. Montefiori,Norman L. Letvin	36
6	HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3 2007 ·Virology ·Anthony D. Cristillo,Julianna Lisziewicz,Leilei He,Franco Lori,Lindsey Galmin,Jeffrey Trocio,(unknown),Lucia Whitman,Lauren Hudacik,Nyasha Bakare,Stephen Whitney,(unknown),John J. Suschak,(unknown),(unknown),Vaniambadi S. Kalyanaraman,Phillip D. Markham,Ranajit Pal	27
7	Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes 2006 ·The Journal of Immunology ·Zdeněk Hel,Wen-Po Tsai,Elżbieta Tryniszewska,János Nacsa,Phillip D. Markham,Mark G. Lewis,George N. Pavlakis,Barbara K. Felber,Jim Tartaglia,Genoveffa Franchini	49
8	Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype 2006 ·Virology ·Ranajit Pal,Shixia Wang,V. S. Kalyanaraman,B.C. Nair,Stephen Whitney,(unknown),(unknown),Lauren Hudacik,Nicolas Rose,Innocent Mboudjeka,Siyuan Shen,(unknown),David C. Montefiori,John R. Mascola,Phillip D. Markham,Shan Lu	73
9	Long Lasting Control and Lack of Pathogenicity of the Attenuated Rev-Independent SIV in Rhesus Macaques 2006 ·AIDS Research and Human Retroviruses ·(unknown),Candido Alicea,Antonio Valentin,Matthew P. Morrow,Koen K. A. Van Rompay,(unknown),Phillip D. Markham,James G. Else,Marta L. Marthas,George N. Pavlakis,Ruth M. Ruprecht,Barbara K. Felber	8
10	Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques 2006 ·Vaccine ·Raúl Gómez Román,George Grimes,(unknown),Bo Peng,Thorsten Demberg,(unknown),(unknown),Ranajit Pal,Eun Mi Lee,W. Gregory Alvord,Phillip D. Markham,Marjorie Robert-Guroff	21
11	Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine 2005 ·Virology ·Anthony D. Cristillo,Shixia Wang,(unknown),(unknown),(unknown),Leilei He,Lauren Hudacik,Stephen Whitney,(unknown),Te-Hui Chou,Siyuan Shen,Swati Joshi,Vaniambadi S. Kalyanaraman,(unknown),Phillip D. Markham,Shan Lu,Ranajit Pal	38
12	Polyvalent DNA prime and envelope protein boost HIV‐1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate 2005 ·Journal of Medical Primatology ·Ranajit Pal,Shixia Wang,V. S. Kalyanaraman,B.C. Nair,Stephen Whitney,(unknown),(unknown),Lauren Hudacik,Nicolas Rose,Anthony D. Cristillo,Innocent Mboudjeka,Siyuan Shen,(unknown),David C. Montefiori,John R. Mascola,Shan Lu,Phillip D. Markham	49
13	Species-specific transformation of T cells by HVMNE 2003 ·Virology ·Maria Grazia Ferrari,Liljana Stevceva,Phillip D. Markham,Genoveffa Franchini	0
14	Comparison of Vaccine Strategies Using Recombinant env–gag–pol MVA with or without an Oligomeric Env Protein Boost in the SHIV Rhesus Macaque Model 2002 ·Virology ·Patricia L. Earl,Linda S. Wyatt,David C. Montefiori,Miroslawa Bilska,Ruth Woodward,Phillip D. Markham,James D. Malley,Thorsten U. Vogel,Todd M. Allen,David I. Watkins,N. R. Miller,Bernard Moss	75
15	A Conformational C4 Peptide Polymer Vaccine Coupled with Live Recombinant Vector Priming Is Immunogenic But Does Not Protect against Rectal SIV Challenge 2001 ·AIDS Research and Human Retroviruses ·L. Jean Patterson,Frank A. Robey,(unknown),(unknown),Kristine Aldrich,Ersell Richardson,W. Gregory Alvord,Phillip D. Markham,Martin Cranage,Marjorie Robert-Guroff	17
16	Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques 2000 ·Nature Medicine ·Zdeněk Hel,David Venzon,(unknown),Wen-Po Tsai,Laura Giuliani,Ruth Woodward,Claire Chougnet,Gene M. Shearer,John D. Altman,David I. Watkins,Norbert Bischofberger,Alash’le Abimiku,Phillip D. Markham,James Tartaglia,Genoveffa Franchini	159
17	CD8+ Lymphocyte Antiviral Activity in Monkeys Immunized with SIV Recombinant Poxvirus Vaccines: Potential Role in Vaccine Efficacy 1999 ·AIDS Research and Human Retroviruses ·(unknown),(unknown),David Venzon,Joseph Romano,Phillip D. Markham,Keith Limbach,James Tartaglia,Enzo Paoletti,John M. Benson,Genoveffa Franchini,Marjorie Robert-Guroff	21
18	HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques 1995 ·Nature Medicine ·Alash’le Abimiku,Genoveffa Franchini,James Tartaglia,Kristine Aldrich,(unknown),Phillip D. Markham,Pele Chong,Michel Klein,Marie-Paule Kiény,Enzo Paoletti,Robert C. Gallo,Marjorie Robert-Guroff	61
19	Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6 1989 ·Nature ·Paolo Lusso,Barbara Ensoli,Phillip D. Markham,Dharam V. Ablashi,S. Zaki Salahuddin,Erwin Tschachler,Flossie Wong‐Staal,Robert C. Gallo	245
20	Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6) 1988 ·International Journal of Cancer ·Dharam V. Ablashi,Paolo Lusso,Chia‐Ling Hung,S. Zaki Salahuddin,Steven F. Josephs,T Llana,Bernhard Kramarsky,Peter Biberfeld,Phillip D. Markham,Robert C. Gallo	104

About Phillip D. Markham

Phillip D. Markham is a scholar working on Virology, Immunology and Agronomy and Crop Science, having authored 64 papers that have together received 8.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (38 papers), T-cell and Retrovirus Studies (20 papers) and Herpesvirus Infections and Treatments (20 papers). The work is most often cited by research in Virology (4.1k citations), Immunology (3.2k citations) and Infectious Diseases (2.8k citations). Phillip D. Markham has collaborated with scholars based in United States, Italy and Sweden. Frequent co-authors include Robert C. Gallo, Mark H. Kaplan, S. Zaki Salahuddin, Mikuláš Popovič, Robert R. Redfield, Syed Zaki Salahuddin, Gene M. Shearer, Barton F. Haynes, James M. Oleske and T J Palker. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact